Sheela
Sheela
Home
Add
Questions
Thinkers
Claims
People
Concepts
Jargon
Sources
Health
Predictions
Collections
Domain Landscape
Contribute
Review
Dedup
Topic requests
Settings
Help

← Jargon

Jargonlaw· 2 claims· 1 episode

product hopping

Switching the market to a trivially modified, newly patented version of a drug and withdrawing the original to block generic substitution.

As defined in Robin Feldman on Drug Patents, Generics, and Drug Wars


Where it comes up · 1
  • Robin Feldman on Drug Patents, Generics, and Drug Wars2 claims

Most important claims · 2 of 2Search all claims for “product hopping” →
  • In the Asacol/Delzicol case the company introduced a new patented product identical to the old drug except for an ineffective capsule that did nothing, then withdrew the original Asacol from the market; because pharmacists could not substitute a generic of the now-unavailable original, and generics could not add a matching capsule without infringing the new patent, the maneuver blocked generic competition despite the change being therapeutically meaningless.Robin Feldman on Drug Patents, Generics, and Drug Wars
  • Within Hatch-Waxman, companies practice evergreening and product hopping—making a minor modification to a drug's delivery, dosage, or form right as the patent expires, obtaining a new patent on the trivially changed version, and then withdrawing the old version so generics of the original cannot be substituted.Robin Feldman on Drug Patents, Generics, and Drug Wars